SECURITIES PURCHASE AGREEMENTSecurities Purchase Agreement • January 30th, 2023 • MDNA Life Sciences, Inc. • In vitro & in vivo diagnostic substances • New York
Contract Type FiledJanuary 30th, 2023 Company Industry JurisdictionThis Securities Purchase Agreement (this “Agreement”) is dated as of December __, 2022, between MDNA Life Sciences, Inc., a Delaware corporation (the “Company”), and each purchaser identified on the signature pages hereto (each, including its successors and assigns, a “Purchaser” and collectively, the “Purchasers”).
SECURITIES PURCHASE AGREEMENTSecurities Purchase Agreement • April 11th, 2022 • MDNA Life Sciences, Inc. • Services-commercial physical & biological research • New York
Contract Type FiledApril 11th, 2022 Company Industry JurisdictionThis Securities Purchase Agreement (this “Agreement”) is dated as of September 30, 2021, between MDNA Life Sciences, Inc., a Delaware corporation (the “Company”), and each purchaser identified on the signature pages hereto (each, including its successors and assigns, a “Purchaser” and collectively, the “Purchasers”).